SLC23A1 and non-Hodgkin lymphoma: Some variations in SLC23A1 were reviewed as associated with an increased risk of Crohn’s disease, non-Hodgkin lymphoma, preterm delivery, and aggressive periodontitis, while some variations in SLX23A2 were shown as being associated with an increased/decreased risk of gastric cancer, increased risk of bladder cancer, and decreased risk of colorectal adenocarcinoma, HPV16-positive head and neck cancer, non-Hodgkin lymphoma, chronic lymphocytic leukemia, preterm delivery open-angle glaucoma, and acute coronary syndrome in women [4].